Growth Metrics

Iradimed (IRMD) Accumulated Depreciation & Amortization (2016 - 2025)

Iradimed (IRMD) has disclosed Accumulated Depreciation & Amortization for 13 consecutive years, with $5.1 million as the latest value for Q4 2025.

  • Quarterly Accumulated Depreciation & Amortization rose 10.38% to $5.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.1 million through Dec 2025, up 10.38% year-over-year, with the annual reading at $5.1 million for FY2025, 10.38% up from the prior year.
  • Accumulated Depreciation & Amortization for Q4 2025 was $5.1 million at Iradimed, up from $4.9 million in the prior quarter.
  • The five-year high for Accumulated Depreciation & Amortization was $5.1 million in Q4 2025, with the low at $134870.0 in Q1 2022.
  • Average Accumulated Depreciation & Amortization over 5 years is $2.6 million, with a median of $2.7 million recorded in 2021.
  • The sharpest move saw Accumulated Depreciation & Amortization tumbled 94.53% in 2022, then surged 2570.51% in 2024.
  • Over 5 years, Accumulated Depreciation & Amortization stood at $532275.0 in 2021, then increased by 7.0% to $569551.0 in 2022, then skyrocketed by 614.57% to $4.1 million in 2023, then grew by 12.9% to $4.6 million in 2024, then grew by 10.38% to $5.1 million in 2025.
  • According to Business Quant data, Accumulated Depreciation & Amortization over the past three periods came in at $5.1 million, $4.9 million, and $4.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.